Mirae Asset Global Investments Co., Ltd. Amicus Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,843 shares of FOLD stock, worth $99,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,843

Previous 211,885 95.83%

Holding current value

$99,041

Previous $2.5 Million 96.51%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$9.04 - $11.75 $1.84 Million - $2.39 Million	-203,042 Reduced 95.83%	8,843 $87,000
Q1 2024 May 01, 2024	SELL	$11.43 - $14.24 $202,528 - $252,318	-17,719 Reduced 7.72%	211,885 $2.5 Million
Q4 2023 Jan 24, 2024	BUY	$9.97 - $14.52 $191,463 - $278,842	19,204 Added 9.13%	229,604 $3.26 Million
Q3 2023 Oct 26, 2023	SELL	$11.78 - $13.86 $102,921 - $121,094	-8,737 Reduced 3.99%	210,400 $2.56 Million
Q2 2023 Aug 10, 2023	BUY	$10.72 - $13.3 $97,423 - $120,870	9,088 Added 4.33%	219,137 $2.75 Million
Q1 2023 May 04, 2023	BUY	$10.91 - $13.54 $261,152 - $324,106	23,937 Added 12.86%	210,049 $2.33 Million
Q4 2022 Feb 09, 2023	SELL	$9.89 - $12.7 $52,179 - $67,005	-5,276 Reduced 2.76%	186,112 $2.27 Million
Q3 2022 Nov 10, 2022	BUY	$9.82 - $12.75 $157,512 - $204,510	16,040 Added 9.15%	191,388 $2 Million
Q2 2022 Jul 26, 2022	BUY	$6.23 - $11.12 $1.09 Million - $1.95 Million	175,348 New	175,348 $1.88 Million
Q2 2021 Aug 11, 2021	SELL	$8.71 - $10.72 $824,061 - $1.01 Million	-94,611 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$9.2 - $23.86 $364,715 - $945,881	39,643 Added 72.12%	94,611 $935,000
Q4 2020 Feb 10, 2021	SELL	$13.47 - $24.89 $281,523 - $520,201	-20,900 Reduced 27.55%	54,968 $1.27 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $977,938 - $1.21 Million	75,868 New	75,868 $1.07 Million
Q1 2020 May 12, 2020	SELL	$6.63 - $11.16 $708,733 - $1.19 Million	-106,898 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$7.48 - $10.75 $67,372 - $96,825	9,007 Added 9.2%	106,898 $1.04 Million
Q3 2019 Nov 12, 2019	BUY	$8.02 - $13.25 $785,085 - $1.3 Million	97,891 New	97,891 $785,000

Others Institutions Holding FOLD

# of Institutions

278

Shares Held

324M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.14B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Amicus Therapeutics, Inc. Transaction History